Cellromax Science셀로맥스사이언스
471820 · KOSDAQ · ₩471820 · 셀로맥스사이언스
₩3,965▼ ₩100 (2.46%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | 50.1% | 47.5% | 56.8% |
| Operating margin | 11.0% | 12.8% | 25.4% |
| Net margin | 19.4% | 13.4% | 17.6% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | −11.6% | +2.6% | — |
| Operating income growth | −24.1% | −48.5% | — |
| Net income growth | +28.3% | −22.3% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | 8.1% | 6.5% | 8.6% |
| Return on assets | 7.5% | 5.9% | 7.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 7.7% | 8.5% | 10.3% |
| Net debt to equity | — | — | −33.3% |
| Current ratio | 598.4% | 520.3% | 978.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Cellromax Science / 셀로맥스사이언스 / 471820 / KRX:471820
Source: KRX statistical information